Unbound MEDLINE

Hydroxyurea and anagrelide combination therapy in patients with chronic myeloproliferative diseases resistant or intolerant to monotherapy. Acta haematologica [Acta Haematol] Journal article

 
TitleHydroxyurea and anagrelide combination therapy in patients with chronic myeloproliferative diseases resistant or intolerant to monotherapy.
Author(s)Christoforidou A, Pantelidou D, Anastasiadis A, Goutzouvelidis A, Margaritis D, Kotsianidis I, Spanoudakis E, Kaloutsi V, Bourikas G, Tsatalas C 
InstitutionDepartment of Haematology, Democritus University of Thrace, Alexandroupolis, Greece. annachristof@yahoo.gr
SourceActa Haematol 2008; 120(4):195-8.
MeSHAdult
Aged
Aged, 80 and over
Drug Resistance
Drug Therapy, Combination
Female
Humans
Hydroxyurea
Male
Middle Aged
Polycythemia Vera
Quinazolines
Thrombocythemia, Essential
Languageeng
Pub Type(s)Journal Article
PubMed ID19129692
  
Advertise on this site.